1. Dent J. An evidence-based appraisal of reflux disease management – the Genval Workshop report. Gut. 1999;(44):1-16. doi: 10.1136/gut.44.2008.s1
2. Di Mario F, Goni E. Gastric acid secretion: changes during a century. Best Pract Res Clin Gastroenterol. 2014;28(6):953-65. doi: 10.1016/j.bpg.2014.10.006
3. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease (GERD) – a global evidence-based consensus. Am J Gastroenterol. 2006;(101):1900-20. doi: 10.1093/pch/14.suppl.a.26a
4. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionare for gastroesophageal reflux disease. Mayo Clin Proe. 1994;69:539-47. doi: 10.1016/s0025-6196(12)62245-9
5. Юренев Г.Л., Самсонов А.А., Юренева-Тхоржевская Т.В. Современный взгляд на кардиальные проявления гастроэзофагеальной рефлюксной болезни. Сonsilium Medicum. 2015;17(12):44-9 [Yurenev GL, Samsonov AA, Yureneva-Tkhorzhevskaya TV. Modern look at cardiac manifestations of gastroesophageal reflux disease. Сonsilium Medicum. 2015;17(12): 44-9 (In Russ.)].
6. Маев И.В., Бурков С.Г., Юренев Г.Л. Гастроэзофагеальная рефлюксная болезнь и ассоциированная патология. М.: Литтерра, 2014. 352 с. [Maev IV, Burkov SG, Yurenev GL. Gastroezofageal'naya reflyuksnaya bolezn' i assotsiirovannaya patologiya [Gastroesophageal Reflux Disease and Associated Pathology]. Moscow: Litterra, 2014. 352 p. (In Russ.)]. 
7. Маев И.В., Трухманов А.С. Неэрозивная рефлюксная болезнь с позиций современной гастроэнтерологии: клинические особенности и влияние на качество жизни пациентов. Русский медицинский журнал. 2004;12(23):1344-8 [Maev IV, Trukhmanov AS. Non-erosive reflux disease from the standpoint of modern gastroenterology: clinical features and the impact on the quality of life of patients. Russkii Meditsinskii Zhurnal. 2004;12(23):1344-8 (In Russ.)].
8. Tytgat GN. Recent developments in gastroesophageal reflux disease and Barrett's esophagus: ANNO 2012. J Dig Dis. 2012;13(6):291-5. doi: 10.1111/j.1751-2980.2012.00598.x
9. Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015;149(2):302-17. doi: 10.1053/j.gastro.2015.04.053
10. Castro AV, Kolka CM, Kim SP, Bergman RN. Obesity, insulin resistance and comorbidities? Mechanisms of association. Arq Bras Endocrinol Metabol. 2014;58(6):600-9.
11. Haidar YM, Cosman BC. Obesity epidemiology. Clin Colon Rectal Surg. 2011;24(4):205-10. doi: 10.3390/ijerph110707425
12. Дедов И.И., Мельниченко Г.А., редакторы. Ожирение: этиология, патогенез, клинические аспекты: Руководство для врачей. М.: Медицинское информационное агентство, 2004 [Dedov II, Mel'nichenko GA, eds. Ozhirenie: etiologiya, patogenez, klinicheskie aspekty: Rukovodstvo dlya vrachey [Obesity: etiology, pathogenesis, clinical aspects: A guide for physicians]. Moscow: Meditsinskoe informatsionnoe agenstvo, 2004 (In Russ.)].
13. Mehta T, Fontaine KR, Keith SW, Bangalore SS, de los Campos G, Bartolucci A, Pajewski NM, Allison DB. Obesity and mortality: are the risks declining? Evidence from multiple prospective studies in the United States. Obes Rev. 2014;15(8):619-29. doi: 10.1111/obr.12191
14. Gray DS. Diagnosis and prevalence of obesity. Med Clin North Am. 1989;73(1):1-13.
15. Ze EY, Kim BJ, Kang H, Kim JG. Abdominal visceral to subcutaneous adipose tissue ratio is associated with increased risk of erosive esophagitis. Dig Dis Sci. 2017;62(5):1265-71. doi: 10.1007/s10620-017-4467-4
16. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. 1956. Nutrition. 1999;15(1):89-90. discussion 1. 
17. Peppa M, Koliaki C, Papaefstathiou A, Garoflos E, Katsilambros N, Raptis SA, Hadjidakis DI, Dimitriadis GD. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women. Obesity (Silver Spring). 2013;21(9):1807-14. doi: 10.1002/oby.20227
18. Slawik M, Vidal-Puig AJ. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev. 2006;5(2):144-64. doi: 10.1016/j.arr.2006.03.004
19. Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14-24. doi: 10.1007/s11684-013-0262-6
20. Chang P, Friedenberg F. Obesity and GERD. Gastroenterol Clin North Am. 2014;43(1):161-73. doi: 10.1016/j.gtc.2013.11.009
21. Ogunwobi O, Mutungi G, Beales IL. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology. 2006;147(9):4505-16. doi: 10.1210/en.2006-0224
22. Rubenstein JH, Kao JY, Madanick RD, Zhang M, Wang M, Spacek MB, Donovan JL, Bright SD, Shaheen NJ. Association of adiponectin multimers with Barrett's oesophagus. Gut. 2009;58(12):1583-9. doi: 10.1136/gut.2008.171553 
23. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006;94(9):1221-5. doi: 10.1038/sj.bjc.6603051
24. Исаченкова О.А. Пищевое поведение как важный фактор развития ожирения и коморбидных с ним заболеваний. Ожирение и метаболизм. 2015;12(4):14-7 [Isachenkova OA. Nutritional behavior as an important factor in the development of obesity and diseases comorbid with it. Ozhirenie i Metabolizm. 2015;12(4):14-7 (In Russ.)].
25. Wadden TA, Phelan S. Assessment of quality of life in obese individuals. Obes Res. 2002 Nov;10 Suppl 1:50-7. doi: 10.1038/oby.2002.190
26. Yanagisawa M, Yu RK. The expression and functions of glycoconjugates in neural stem cells. Glycobiology. 2007 Jul;17(7):57-74. doi: 10.1093/glycob/cwm018
27. Vaishnav B, Bamanikar A, Maske P, Reddy A, Dasgupta S. Gastroesophageal reflux disease and its association with body mass index: clinical and endoscopic study. J Clin Diagn Res. 2017;11(4):01-04. doi: 10.7860/JCDR/2017/24151.9562
28. Suter M, Dorta G, Giusti V, Calmes JM. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg. 2004;14(7):959-66. doi: 10.1381/0960892041719581
29. Quiroga E, Cuenca-Abente F, Flum D. Impaired esophageal function in morbidly obese patients with gastroesophageal reflux disease: evaluation with multichannel intraluminal impedance. Surg Endosc. 2006;20(5):739-43. doi: 10.1007/s00464-005-0268-5
30. Трухманов А.С., Евсютина Ю.В. Изжога при гастроэзофагеальной рефлюксной болезни – механизм развития и подходы к терапии. Русский медицинский журнал. 2017;(10):707-10 [Trukhmanov AS, Evsyutina YuV. Heartburn in gastroesophageal reflux disease – the mechanism of development and approaches to therapy. Russkii Meditsinskii Zhurnal. 2017;(10):707-10 (In Russ.)].
31. Трухманов А.С., Джахая Н.Л., Кайбышева В.О., Сторонова О.А. Новые аспекты рекомендаций по лечению больных гастроэзофагеальной рефлюксной болезнью. Гастроэнтерология и гепатология. 2013;1(4):1-9 [Truhmanov AS, Dzhahaja NL, Kajbysheva VO, Storonova OA. New aspects of treatment recommendations for patients with gastroesophageal reflux disease. Gastrojenterologija i Gepatologija. 2013;1(4):1-9 (In Russ.)].
32. Kouklakis G, Moschos J, Kountouras J, Mpoumponaris A, Molyvas E, Minopoulos G. Relationship between obesity and gastroesophageal reflux disease as recorded by 3-hour esophageal pH monitoring. Rom J Gastroenterol. 2005;14(2):117-21. 
33. Koppman JS, Poggi L, Szomstein S, Ukleja A, Botoman A, Rosenthal R. Esophageal motility disorders in the morbidly obese population. Surg Endosc. 2007 May;21(5):761-4. doi: 10.1007/s00464-006-9102-y
34. Kahrilas PJ, Shi G, Manka M, Joehl RJ. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology. 2000;118(4):688-95. 
35. Fisher BL, Pennathur A, Mutnick JL, Little AG. Obesity correlates with gastroesophageal reflux. Dig Dis Sci. 1999;44(11):2290-4. doi: 10.1023/A:1026617106755
36. Маев И.В., Юренев Г.Л., Бурков С.Г. Многоликая ГЭРБ: проблемы и решения. М.: ГЭОТАР-Медиа; 2015; 386 с. [Маev IV, Yurenev GL, Burkov SG. Mnogolikaya GERB: problemy i resheniya [The Many Faces of GERD: problems and solutions]. Мoscow: ­GEOTAR-Media; 2015. 386 p. (In Russ.)].
37. Wu JC, Mui LM, Cheung CM, Chan Y, Sung JJ. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132(3):883-9. doi: 10.1053/j.gastro.2006.12.032
38. Bredenoord AJ. Mechanisms of reflux perception in gastroesophageal reflux disease: a review. Am J Gastroenterol. 2012;107(1):8-15. doi: 10.1038/ajg.2011.286
39. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130(3):639-49. doi: 10.1053/j.gastro.2005.12.016
40. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290(1):66-72. doi: 10.1001/jama.290.1.66
41. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100(6):1243-50. doi: 10.1111/j.1572-0241.2005.41703.x
42. Jacobson BC, Somers S.C., Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006 Jun 1;354(22):2340-8.
43. Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux – a population-based study. Aliment Pharmacol Ther. 2006;23(1):169-74. doi: 10.1111/j.1365-2036.2006.02727.x
44. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR 3rd, Rodriguez-Artalejo F. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther. 2004;19(1):95-105.
45. Kang MS, Park DI, Oh SY, Yim HJ, Chun HJ, Lee HS. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population. J Gastroenterol Hepatol. 2007;22(10):1656-61. doi: 10.1111/j.1440-1746.2006.04518.x
46. Ma XQ, Cao Y, Wang R, Yan X, Zhao Y, Zou D, Wallander M-A, Johansson S, Liu W, Gu Z, Zhao J, He J. Prevalence of, and factors associated with, gastroesophageal reflux disease: a population-based study in Shanghai, China. Dis Esophagus. 2009;22(4):317-22. doi: 10.1111/j.1442-2050.2008.00904.x
47. Lagergren J, Bergstrom R, Nyren O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut. 2000;47(1):26-9.
48. Lee HL, Eun CS, Lee OY. Association between GERD-related erosive esophagitis and obesity. J Clin Gastroenterol. 2008;42(6):672-5. doi: 10.1097/MCG.0b013e31806daf64
49. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199-211.
50. El-Serag HB, Hashmi A, Garcia J, Richardson P, Alsarraj A, Fitzgerald S, Vela M, Shaib Y, Abraham NS, Velez M, Cole R, Rodriguez MB, Anand B, Graham DY, Kramer JR. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett’s oesophagus: a case-control study. Gut. 2013. doi: 10.1136/gutjnl-2012-304189
51. Rubenstein JH, Morgenstern H, Chey WD. Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett’s oesophagus. Gut. 2013. doi: 10.1136/gutjnl-2012-304103
52. Smith KJ, O'Brien SM, Smithers BM, Gotley DC, Webb PM, Green AC, Whiteman DC. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev. 2005;14(11 Pt 1):2481-6. doi: 10.1158/1055-9965.EPI-05-0370
53. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142-6. doi: 10.1093/jnci/dji024
54. Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraume JF Jr. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90(2):150-5.
55. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Wu AH, Ward MH, Casson AG, Murray LJ, Corley DA, Nyrén O, Pandeya N, Vaughan TL, Chow WH, Gammon MD. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41(6):1706-18. doi: 10.1093/ije/dys176
56. Weigle DS. Leptin and other secretory products of adipocytes modulate multiple physiological functions. Ann Endocrinol (Paris). 1997;58(2):132-6.
57. Rubenstein JH, Dahlkemper A, Kao JY, Zhang M, Morgenstern H, McMahon L, Inadomi JM. A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol. 2008;103(6):1358-64. doi: 10.1111/j.1572-0241.2008.01823.x
58. Ливзан М.А., Лаптева И.В., Кролевец Т.С., Киселев И.Е. Специфические особенности ГЭРБ, связанной с ожирением и избыточной массой тела. Терапевтический архив. 2016;88(2):21-7 [Livzan MA, Lapteva IV, Krolevetz TS, Kiselev IE. Specific features of GERD associated with obesity and overweight. Therapeutic Archive. 2016;88(2):21-7 (In Russ.)].
59. Anand G, Katz PO. Gastroesophageal reflux disease and obesity. Gastroenterol Clin North Am. 2010 Mar;39(1):39-46. doi: 10.1016/j.gtc.2009.12.002
60. Kotlyar M, Carson SW. Effects of obesity on the cytochrome P450 enzyme system. Int J Clin Pharmacol Ther. 1999;37(1):8-19. 
61. Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet. 2000;39:215-31.

________________________________________________

1. Dent J. An evidence-based appraisal of reflux disease management – the Genval Workshop report. Gut. 1999;(44):1-16. doi: 10.1136/gut.44.2008.s1
2. Di Mario F, Goni E. Gastric acid secretion: changes during a century. Best Pract Res Clin Gastroenterol. 2014;28(6):953-65. doi: 10.1016/j.bpg.2014.10.006
3. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease (GERD) – a global evidence-based consensus. Am J Gastroenterol. 2006;(101):1900-20. doi: 10.1093/pch/14.suppl.a.26a
4. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionare for gastroesophageal reflux disease. Mayo Clin Proe. 1994;69:539-47. doi: 10.1016/s0025-6196(12)62245-9
5. Yurenev GL, Samsonov AA, Yureneva-Tkhorzhevskaya TV. Modern look at cardiac manifestations of gastroesophageal reflux disease. Сonsilium Medicum. 2015;17(12): 44-9 (In Russ.)
6. Maev IV, Burkov SG, Yurenev GL. Gastroezofageal'naya reflyuksnaya bolezn' i assotsiirovannaya patologiya [Gastroesophageal Reflux Disease and Associated Pathology]. Moscow: Litterra, 2014. 352 p. (In Russ.) 
7. Maev IV, Trukhmanov AS. Non-erosive reflux disease from the standpoint of modern gastroenterology: clinical features and the impact on the quality of life of patients. Russkii Meditsinskii Zhurnal. 2004;12(23):1344-8 (In Russ.)
8. Tytgat GN. Recent developments in gastroesophageal reflux disease and Barrett's esophagus: ANNO 2012. J Dig Dis. 2012;13(6):291-5. doi: 10.1111/j.1751-2980.2012.00598.x
9. Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015;149(2):302-17. doi: 10.1053/j.gastro.2015.04.053
10. Castro AV, Kolka CM, Kim SP, Bergman RN. Obesity, insulin resistance and comorbidities? Mechanisms of association. Arq Bras Endocrinol Metabol. 2014;58(6):600-9.
11. Haidar YM, Cosman BC. Obesity epidemiology. Clin Colon Rectal Surg. 2011;24(4):205-10. doi: 10.3390/ijerph110707425
12. Dedov II, Mel'nichenko GA, eds. Ozhirenie: etiologiya, patogenez, klinicheskie aspekty: Rukovodstvo dlya vrachey [Obesity: etiology, pathogenesis, clinical aspects: A guide for physicians]. Moscow: Meditsinskoe informatsionnoe agenstvo, 2004 (In Russ.)
13. Mehta T, Fontaine KR, Keith SW, Bangalore SS, de los Campos G, Bartolucci A, Pajewski NM, Allison DB. Obesity and mortality: are the risks declining? Evidence from multiple prospective studies in the United States. Obes Rev. 2014;15(8):619-29. doi: 10.1111/obr.12191
14. Gray DS. Diagnosis and prevalence of obesity. Med Clin North Am. 1989;73(1):1-13.
15. Ze EY, Kim BJ, Kang H, Kim JG. Abdominal visceral to subcutaneous adipose tissue ratio is associated with increased risk of erosive esophagitis. Dig Dis Sci. 2017;62(5):1265-71. doi: 10.1007/s10620-017-4467-4
16. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. 1956. Nutrition. 1999;15(1):89-90. discussion 1. 
17. Peppa M, Koliaki C, Papaefstathiou A, Garoflos E, Katsilambros N, Raptis SA, Hadjidakis DI, Dimitriadis GD. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women. Obesity (Silver Spring). 2013;21(9):1807-14. doi: 10.1002/oby.20227
18. Slawik M, Vidal-Puig AJ. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev. 2006;5(2):144-64. doi: 10.1016/j.arr.2006.03.004
19. Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14-24. doi: 10.1007/s11684-013-0262-6
20. Chang P, Friedenberg F. Obesity and GERD. Gastroenterol Clin North Am. 2014;43(1):161-73. doi: 10.1016/j.gtc.2013.11.009
21. Ogunwobi O, Mutungi G, Beales IL. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology. 2006;147(9):4505-16. doi: 10.1210/en.2006-0224
22. Rubenstein JH, Kao JY, Madanick RD, Zhang M, Wang M, Spacek MB, Donovan JL, Bright SD, Shaheen NJ. Association of adiponectin multimers with Barrett's oesophagus. Gut. 2009;58(12):1583-9. doi: 10.1136/gut.2008.171553 
23. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006;94(9):1221-5. doi: 10.1038/sj.bjc.6603051
24. Isachenkova OA. Nutritional behavior as an important factor in the development of obesity and diseases comorbid with it. Ozhirenie i Metabolizm. 2015;12(4):14-7 (In Russ.)
25. Wadden TA, Phelan S. Assessment of quality of life in obese individuals. Obes Res. 2002 Nov;10 Suppl 1:50-7. doi: 10.1038/oby.2002.190
26. Yanagisawa M, Yu RK. The expression and functions of glycoconjugates in neural stem cells. Glycobiology. 2007 Jul;17(7):57-74. doi: 10.1093/glycob/cwm018
27. Vaishnav B, Bamanikar A, Maske P, Reddy A, Dasgupta S. Gastroesophageal reflux disease and its association with body mass index: clinical and endoscopic study. J Clin Diagn Res. 2017;11(4):01-04. doi: 10.7860/JCDR/2017/24151.9562
28. Suter M, Dorta G, Giusti V, Calmes JM. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg. 2004;14(7):959-66. doi: 10.1381/0960892041719581
29. Quiroga E, Cuenca-Abente F, Flum D. Impaired esophageal function in morbidly obese patients with gastroesophageal reflux disease: evaluation with multichannel intraluminal impedance. Surg Endosc. 2006;20(5):739-43. doi: 10.1007/s00464-005-0268-5
30. Trukhmanov AS, Evsyutina YuV. Heartburn in gastroesophageal reflux disease – the mechanism of development and approaches to therapy. Russkii Meditsinskii Zhurnal. 2017;(10):707-10 (In Russ.)
31. Truhmanov AS, Dzhahaja NL, Kajbysheva VO, Storonova OA. New aspects of treatment recommendations for patients with gastroesophageal reflux disease. Gastrojenterologija i Gepatologija. 2013;1(4):1-9 (In Russ.)
32. Kouklakis G, Moschos J, Kountouras J, Mpoumponaris A, Molyvas E, Minopoulos G. Relationship between obesity and gastroesophageal reflux disease as recorded by 3-hour esophageal pH monitoring. Rom J Gastroenterol. 2005;14(2):117-21. 
33. Koppman JS, Poggi L, Szomstein S, Ukleja A, Botoman A, Rosenthal R. Esophageal motility disorders in the morbidly obese population. Surg Endosc. 2007 May;21(5):761-4. doi: 10.1007/s00464-006-9102-y
34. Kahrilas PJ, Shi G, Manka M, Joehl RJ. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology. 2000;118(4):688-95. 
35. Fisher BL, Pennathur A, Mutnick JL, Little AG. Obesity correlates with gastroesophageal reflux. Dig Dis Sci. 1999;44(11):2290-4. doi: 10.1023/A:1026617106755
36. Маev IV, Yurenev GL, Burkov SG. Mnogolikaya GERB: problemy i resheniya [The Many Faces of GERD: problems and solutions]. Мoscow: ­GEOTAR-Media; 2015. 386 p. (In Russ.)
37. Wu JC, Mui LM, Cheung CM, Chan Y, Sung JJ. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132(3):883-9. doi: 10.1053/j.gastro.2006.12.032
38. Bredenoord AJ. Mechanisms of reflux perception in gastroesophageal reflux disease: a review. Am J Gastroenterol. 2012;107(1):8-15. doi: 10.1038/ajg.2011.286
39. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130(3):639-49. doi: 10.1053/j.gastro.2005.12.016
40. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290(1):66-72. doi: 10.1001/jama.290.1.66
41. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100(6):1243-50. doi: 10.1111/j.1572-0241.2005.41703.x
42. Jacobson BC, Somers S.C., Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006 Jun 1;354(22):2340-8.
43. Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux – a population-based study. Aliment Pharmacol Ther. 2006;23(1):169-74. doi: 10.1111/j.1365-2036.2006.02727.x
44. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR 3rd, Rodriguez-Artalejo F. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther. 2004;19(1):95-105.
45. Kang MS, Park DI, Oh SY, Yim HJ, Chun HJ, Lee HS. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population. J Gastroenterol Hepatol. 2007;22(10):1656-61. doi: 10.1111/j.1440-1746.2006.04518.x
46. Ma XQ, Cao Y, Wang R, Yan X, Zhao Y, Zou D, Wallander M-A, Johansson S, Liu W, Gu Z, Zhao J, He J. Prevalence of, and factors associated with, gastroesophageal reflux disease: a population-based study in Shanghai, China. Dis Esophagus. 2009;22(4):317-22. doi: 10.1111/j.1442-2050.2008.00904.x
47. Lagergren J, Bergstrom R, Nyren O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut. 2000;47(1):26-9.
48. Lee HL, Eun CS, Lee OY. Association between GERD-related erosive esophagitis and obesity. J Clin Gastroenterol. 2008;42(6):672-5. doi: 10.1097/MCG.0b013e31806daf64
49. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199-211.
50. El-Serag HB, Hashmi A, Garcia J, Richardson P, Alsarraj A, Fitzgerald S, Vela M, Shaib Y, Abraham NS, Velez M, Cole R, Rodriguez MB, Anand B, Graham DY, Kramer JR. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett’s oesophagus: a case-control study. Gut. 2013. doi: 10.1136/gutjnl-2012-304189
51. Rubenstein JH, Morgenstern H, Chey WD. Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett’s oesophagus. Gut. 2013. doi: 10.1136/gutjnl-2012-304103
52. Smith KJ, O'Brien SM, Smithers BM, Gotley DC, Webb PM, Green AC, Whiteman DC. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev. 2005;14(11 Pt 1):2481-6. doi: 10.1158/1055-9965.EPI-05-0370
53. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142-6. doi: 10.1093/jnci/dji024
54. Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraume JF Jr. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90(2):150-5.
55. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Wu AH, Ward MH, Casson AG, Murray LJ, Corley DA, Nyrén O, Pandeya N, Vaughan TL, Chow WH, Gammon MD. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41(6):1706-18. doi: 10.1093/ije/dys176
56. Weigle DS. Leptin and other secretory products of adipocytes modulate multiple physiological functions. Ann Endocrinol (Paris). 1997;58(2):132-6.
57. Rubenstein JH, Dahlkemper A, Kao JY, Zhang M, Morgenstern H, McMahon L, Inadomi JM. A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol. 2008;103(6):1358-64. doi: 10.1111/j.1572-0241.2008.01823.x
58. Livzan MA, Lapteva IV, Krolevetz TS, Kiselev IE. Specific features of GERD associated with obesity and overweight. Therapeutic Archive. 2016;88(2):21-7 (In Russ.)
59. Anand G, Katz PO. Gastroesophageal reflux disease and obesity. Gastroenterol Clin North Am. 2010 Mar;39(1):39-46. doi: 10.1016/j.gtc.2009.12.002
60. Kotlyar M, Carson SW. Effects of obesity on the cytochrome P450 enzyme system. Int J Clin Pharmacol Ther. 1999;37(1):8-19. 
61. Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet. 2000;39:215-31.

И.В. Маев, Г.Л. Юренев, Е.М. Миронова, Т.В. Юренева-Тхоржевская

ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России, Москва

________________________________________________

I.V. Maev, G.L. Yurenev, E.M. Mironova, T.V. Yureneva-Thorzhevskaya

A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation, Moscow, Russia